Angiogenic factors are controlled by hypoxia-inducible factors (HIFs), the mechanistic target of rapamycin (mTOR), and the unfolded protein response (UPR): they both provide immunomodulatory and vascular actions in the tumor microenvironment. The gene discussed is MTOR; the disease is neoplasm.